Cholangiocarcinoma

Paul J. Brindley(George Washington University), Gregory J. Gores(Mayo Clinic in Arizona)
Nature Reviews Disease Primers
September 9, 2021
10.1038/s41572-021-00300-2
Cited by 830

Related Papers

Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.4k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
|Journal of Biological Chemistry|2006|718
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709